Observational studyEuropean journal of clinical pharmacology2021

Effect of SAcubitril/Valsartan on left vEntricular ejection fraction and on the potential indication for Implantable Cardioverter Defibrillator in primary prevention: the SAVE-ICD study.

Federico Guerra et al.PubMed ↗Publisher ↗

No numbers read from the abstract.